NUTX · Nutex Health Inc. · Insider Trading

Restricted stock units convert into common stock on a one-for-one basis.

Restricted stock units convert into common stock on a one-for-one basis.

Restricted stock units convert into common stock on a one-for-one basis.

Restricted stock units convert into common shares on a one-for-one basis.

Michael L Reed Trust IRA ("MLRTIRA"), the direct beneficial owner of 67 shares of Common Stock. Michael L Reed, the sole trustee of MLRTIRA, is the indirect beneficial owner of such shares.

Represents the issuance in private transaction of 2,519 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of one under construction hospital previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.

Represents the issuance in private transaction of 62,994 and 12,753 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.

Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Represents the issuance in private transaction of 95,076 and 88,995 shares of common stock, respectively, with respect to the Issuer's one-time obligations related to the reporting person's pro-rata share of two under construction hospitals previously transferred to Nutex Health Holdco LLC pursuant to the Agreement and Plan of Merger dated November 23, 2021, as described in the Issuer's definitive proxy statement on Schedule 14A filed with the Securities and Exchange Commission (SEC) on February 14, 2022, as supplemented, and the Form 10-K filed with the SEC on March 5, 2026.

Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of the securities of the registrant reported herein.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On March 11, 2026, the Reporting Person was granted 2,411 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Restricted stock units convert into common stock on a one-for-one basis.

On March 11, 2026, the Reporting Person was granted 1,694 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Of the 6,293 shares issued subsequent to vesting, 3,274 shares were sold to cover tax withholding obligations.

Of the 183 shares issued subsequent to vesting, 82 shares were sold to cover tax withholding obligations.

Restricted stock units convert into common stock on a one-for-one basis.

On March 11, 2026, the Reporting Person was granted 116 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Of the 2,084 shares issued subsequent to vesting, 769 shares were sold to cover tax withholding obligations.

Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.

Of the 2,084 shares issued subsequent to vesting, 784 shares were sold to cover tax withholding obligations.

The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.

This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

Restricted stock units convert into common stock on a one-for-one basis.

On March 10, 2026, the Reporting Person was granted 1,936 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Restricted stock units that convert into common stock on a one-for-one basis upon vesting.

Of the 8,334 shares issued subsequent to vesting, 3,017 shares were sold to cover tax withholding obligations.

Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,840,898 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

Of the 2,084 shares issued subsequent to vesting, 776 shares were sold to cover tax withholding obligations.

Restricted stock units convert into common stock on a one-for-one basis.

On March 11, 2026, the Reporting Person was granted 3,656 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Restricted stock units convert into common stock on a one-for-one basis.

On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Restricted stock units that convert into common stock on a one-for-one basis upon vesting.

On March 11, 2026, the Reporting Person was granted 1,525 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

Restricted stock units convert into common stock on a one-for-one basis.

The Reporting Person directly owns 2,360 shares. Additionally, the Reporting Person indirectly owns 10 shares through their spouse, resulting in a total beneficial ownership of 2,370 shares.

Restricted stock units convert into common stock on a one-for-one basis.

On March 11, 2026, the Reporting Person was granted 4,841 RSUs, which vest in three equal installments on March 1, 2027, March 1, 2028, and March 1, 2029.

This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 10, 2026 relating to a transaction dated March 10, 2026.

Restricted stock units convert into common stock on a one-for-one basis.

Restricted stock units convert into common stock on a one-for-one basis.

Thomas T. Vo, the Chairman and CEO of the registrant, owns and controls Micro Hospital Holding LLC, the direct owner of 1,840,898 of the securities of the registrant reported herein and the sole trustee of Vo Family Limited Partnership, the direct owner of 23,914 of the securities of the registrant reported herein.

Restricted stock units convert into common stock on a one-for-one basis.

This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

Restricted stock units convert into common stock on a one-for-one basis.

Restricted stock units convert into common stock on a one-for-one basis.

Michael Chang PLLC ("CHANG") is the direct beneficial owner of 82,356 shares of Common Stock. Dr. Chang as the 100% owner and sole manager of CHANG, is an indirect beneficial owner of such shares. Dr. Chang is the direct owner of 984 shares.

This Form 4 corrects the number of restricted stock units (RSUs) beneficially owned following the RSU grant reported in the reporting person's Form 4 filed on March 11, 2026 relating to a transaction dated March 10, 2026.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

On July 14, 2025, the Reporting Person was granted 603 RSUs, which vest 100% on July 14, 2026. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.

Of the 143 shares issued subsequent to vesting, 34 shares were sold to cover tax withholding obligations.

Of the shares 3,776 issued subsequent to vesting, 1,072 shares were sold to cover tax withholding obligations.

Of the 2,125 shares issued subsequent to vesting, 452 shares were sold to cover tax withholding obligations.